Novel clearance of muscle proteins by muscle cells.


Journal

European journal of cell biology
ISSN: 1618-1298
Titre abrégé: Eur J Cell Biol
Pays: Germany
ID NLM: 7906240

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 27 01 2020
revised: 11 10 2020
accepted: 29 10 2020
pubmed: 10 11 2020
medline: 4 8 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

Blood levels of cardiac troponins (cTn) and myoglobin are analysed when myocardial infarction (MI) is suspected. Here we describe a novel clearance mechanism for muscle proteins by muscle cells. The complete plasma clearance profile of cTn and myoglobin was followed in rats after intravenous or intermuscular injections and analysed by PET and fluorescence microscopy of muscle biopsies and muscle cells. Compared with intravenous injections, only 5 % of cTnT, 0.6 % of cTnI and 8 % of myoglobin were recovered in the circulation following intramuscular injection. In contrast, 47 % of the renal filtration marker FITC-sinistrin and 81 % of cTn fragments from MI-patients were recovered after intramuscular injection. In addition, PET and biopsy analysis revealed that cTn was taken up by the quadriceps muscle and both cTn and myoglobin were endocytosed by cultured muscle cells. This local clearance mechanism could possibly be the dominant clearance mechanism for cTn, myoglobin and other muscle damage biomarkers released by muscle cells.

Identifiants

pubmed: 33162173
pii: S0171-9335(20)30066-2
doi: 10.1016/j.ejcb.2020.151127
pii:
doi:

Substances chimiques

Muscle Proteins 0
Tnni3k protein, mouse EC 2.7.-
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151127

Informations de copyright

Copyright © 2020 Elsevier GmbH. All rights reserved.

Auteurs

Aida Muslimovic (A)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Vincent Fridén (V)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Karin Starnberg (K)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Olav Tenstad (O)

Department of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Heidi Espedal (H)

Department of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Kristina Vukusic (K)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Susanne Nyström (S)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Emelie Wesén (E)

Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, Kemivägen 10, 41296, Göteborg, Sweden.

Elin K Esbjörner (EK)

Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, Kemivägen 10, 41296, Göteborg, Sweden.

Kristoffer Granholm (K)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Bertil Lindahl (B)

Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Sweden.

Ola Hammarsten (O)

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: ola.hammarsten@clinchem.gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH